User profiles for Susan J.M. Hahné

Susan Hahné

RIVM
Verified email at rivm.nl
Cited by 6303

[HTML][HTML] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - BMC infectious …, 2013 - Springer
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection
is improving but not benefiting individuals unaware to be infected. To inform screening …

[HTML][HTML] Protection of COVID-19 vaccination and previous infection against Omicron BA. 1, BA. 2 and Delta SARS-CoV-2 infections

…, L Ali, B Vlaemynck, R Schepers, SJM Hahné… - Nature …, 2022 - nature.com
Given the emergence of the SARS-CoV-2 Omicron BA.1 and BA.2 variants and the roll-out
of booster COVID-19 vaccination, evidence is needed on protection conferred by primary …

[HTML][HTML] Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis

…, HE de Melker, SJM Hahné - The Lancet Infectious …, 2019 - thelancet.com
Background Measles is an important cause of death in children, despite the availability of
safe and cost-saving measles-containing vaccines (MCVs). The first MCV dose (MCV1) is …

[HTML][HTML] Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden

…, B de Gier, A van der Ende, SJM Hahné… - The Lancet Global …, 2022 - thelancet.com
Background Group B streptococcus (GBS) colonisation during pregnancy can lead to invasive
GBS disease (iGBS) in infants, including meningitis or sepsis, with a high mortality risk. …

Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review

B Purcell, S Samuelsson, SJM Hahné, I Ehrhard… - Bmj, 2004 - bmj.com
Objective To summarise the evidence for the role of antibiotics in preventing further cases of
meningococcal disease through chemoprophylaxis given to the index patient, household …

Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage

S Waaijenborg, SJM Hahné, L Mollema… - The Journal of …, 2013 - academic.oup.com
Background. The combined measles, mumps, and rubella (MMR) vaccine has been successfully
administered for >20 years. Because of this, protection by maternal antibodies in infants …

[HTML][HTML] Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B. 1.617. 2), the Netherlands, August to …

…, S Andeweg, JA Backer, SJM Hahné… - …, 2021 - eurosurveillance.org
We estimated SARS-CoV-2 vaccine effectiveness against onward transmission by comparing
secondary attack rates among household members for vaccinated and unvaccinated index …

[HTML][HTML] Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands …

…, J van de Kassteele, SJM Hahné… - …, 2021 - eurosurveillance.org
… =Susan+JM+Hahn%C3%A9&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hahné
Susan JM</a>, <a href="/search?value1=Susan+… ">van den Hof Susan</a>, <a …

Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective

IK Veldhuijzen, M Toy, SJM Hahné, GA De Wit… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Persons with chronic hepatitis B virus (HBV) infection are at risk of
developing cirrhosis and hepatocellular carcinoma. Early detection of chronic HBV infection …

[HTML][HTML] Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology

…, R van Binnendijk, SJM Hahné… - Nature …, 2023 - nature.com
An increasing proportion of the population has acquired immunity through COVID-19 vaccination
and previous SARS-CoV-2 infection, ie, hybrid immunity, possibly affecting the risk of …